Author name: Sreenivasulu Malkari

Blog

Zerodha CEO Nithin Kamath shares pitfalls of broking business, wonders: Why the brokerage business looks so sexy

Concentration Risk: The Unseen Threat Kamath’s warning is not without merit. The Indian broking industry has been plagued by concentration risk, where a small number of active traders contribute to most of the exchange turnover. This phenomenon has been exacerbated by the rise of online trading platforms, which have made it easier for traders to […]

Blog

Travel Food Services IPO listing on July 14: Here’s what GMP, subscription status hint ahead of debut

Travel Food Services IPO Subscription Status The Travel Food Services IPO was open for subscription from July 7 to July 9, and the company received a healthy response from investors. The IPO was oversubscribed, with Qualified Institutional Buyers (QIBs) subscribing 7.70 times, Non-Institutional Investors (NIIs) subscribing 1.58 times, and Retail Investors subscribing 69%.

Blog

Anthem Biosciences IPO day 3 Live: GMP, subscription status, review, other details. Buy or not?

Anthem Biosciences IPO: A Comprehensive Review and Analysis Anthem Biosciences Limited, a Contract Research, Development, and Manufacturing Organization (CRDMO), has hit the Indian primary market with its initial public offering (IPO) on Monday, July 14. The public issue will remain open until 16 July 2025, aiming to raise ₹3,395 crore from this entirely offer-for-sale (OFS)

Scroll to Top